Cardiac Sca-1+ cells are not intrinsic stem cells for myocardial development, renewal and repair by Zhang, Lu et al.
Cardiac Sca-1+ cells are not intrinsic stem cells for myocardial 
development, renewal and repair
Lu Zhang, PhD#1,2, Nishat Sultana, PhD#2,3, Jianyun Yan, PhD#4, Fan Yang, PhD1,2, Fuxue 
Chen, PhD5, Elena Chepurko, DVM3, Feng-Chun Yang, MD, PhD6, Qinghua Du, MS6, Lior 
Zangi, PhD3, Mingjiang Xu, MD, PhD6, Lei Bu, PhD7, and Chen-Leng Cai, PhD1,2,*
1Riley Heart Research Center, and Herman B Wells Center for Pediatric Research, Indiana 
University School of Medicine, 1044 West Walnut Street, Indianapolis, Indiana 46202, USA
2Department of Developmental and Regenerative Biology, and The Black Family Stem Cell 
Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA
3Department of Medicine, and Cardiovascular Research Center, Icahn School of Medicine at 
Mount Sinai, New York, New York 10029, USA
4Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical 
University, Guangdong Provincial Biomedical Engineering Technology Research Center for 
Cardiovascular Disease, and Sino-Japanese Cooperation Platform for Translational Research in 
Heart Failure, Guangzhou, Guangdong 510280, China
5College of Life Sciences, Shanghai University, Shanghai 200444, China
6Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, 
University of Miami Miller School of Medicine, Miami, Florida 33136, USA
7Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, New 
York 10016, USA
#
 These authors contributed equally to this work.
Abstract
Background: For over a decade, Sca-1+ cells within the mouse heart have been widely 
recognized as a stem cell population with multipotency that can give rise to cardiomyocytes, 
endothelial cells and smooth muscle cells in vitro and after cardiac grafting. However, the 
developmental origin and authentic nature of these cells remain elusive.
Methods: Here, we used a series of high-fidelity genetic mouse models to characterize the 
identity and regenerative potential of cardiac resident Sca-1+ cells.
Results: With these novel genetic mouse models, we found that Sca-1 does not label cardiac 
precursor cells during early embryonic heart formation. Postnatal cardiac resident Sca-1+ cells are 
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in fact a pure endothelial cell population. They retain endothelial properties and exhibit minimal 
cardiomyogenic potential during development, normal aging and upon ischemic injury.
Conclusions: Our study provides definitive insights into the nature of cardiac resident Sca-1+ 
cells. The observations challenge the current dogma that cardiac resident Sca-1+ cells are intrinsic 
stem cells for myocardial development, renewal and repair and suggest that the mechanisms of 
transplanted Sca-1+ cells in heart repair need to be reassessed.
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Introduction
Whether mammalian hearts harbor a population of intrinsic stem cells for myocardial 
renewal and repair and, if they do, how to identify these cells for use in cell-based therapy 
for heart failure are central questions in cardiac regenerative medicine1–5. In the past two 
decades, tremendous efforts have been made to search for such cells, and many forms of 
cardiac stem cells (CSCs) have been identified1, 2. Recently, the nature of c-Kit+ CSCs and 
their function in heart repair were questioned6–10. Three independent groups coincidentally 
indicated that cardiac c-Kit+ cells lack myogenic potential during heart development and 
repair11–13.
Murine stem cell antigen-1 (Sca-1) is a member of the Ly-6 gene family (gene name 
Ly6a)14, 15. Sca-1 encodes a cell surface protein widely used to enrich hematopoietic stem 
cells (HSCs) from the bone marrow (BM)14, 16. With this perception, Sca-1 has been 
persistently thought to be a marker to identify adult stem cells in multiple organs17–21. 
Cardiac Sca-1+ cells were one of the first putative CSCs identified in the adult mouse 
heart22–26, and are found distributed in diverse CSC subtypes in mice (e.g., cardiospheres, 
side populations, and cardiac colony-forming unit fibroblasts)27–32. The human equivalent of 
the murine Sca-1 ortholog has not been identified. However, Sca-1+-like cells were isolated 
from the adult human heart using an anti-mouse Sca-1 antibody and showed cardiomyogenic 
potential when cultured in vitro33. Importantly, a phase I clinical trial (CADUCEUS) was 
performed in which autologous Sca-1-related cardiosphere-derived cells were administered 
to patients with myocardial infarction (MI). Reduced scar size with improved cardiac 
function was observed in the patients34.
Despite these findings, questions have been raised regarding the mechanisms of Sca-1+ cells 
in heart repair. In transplantation of exogenously expanded Sca-1+ cells, the number of 
identifiable engrafted cells has been found to be extremely low (<0.5%), and thus, they are 
unlikely to contribute to functional heart repair through myocardial differentiation35. The 
myogenic potential of engrafted Sca-1+ cells may also require further investigation because 
the conclusions are mainly based on immunostaining with potential microscopic 
artifacts36, 37. In addition, previous reports determining the myogenic potential of cardiac 
Scal-1+ cells have largely relied on in vitro cardiomyogenic differentiation culture 
procedures and that may not represent the nature of endogenous Scal-1+ cells23, 30. 
Furthermore, the developmental origin of cardiac Sca-1+ cells remains largely unknown. 
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These questions raise doubts about whether Sca-1 expression marks bona fide embryonic 
and/or adult CSCs38. In summary, there is an urgent need to define the authentic identity of 
Sca-1+ cells in the developing and adult hearts, to provide definitive answers as to whether 
Sca-1 expression represents a true and applicable CSC population for heart repair.
Methods
The data, analytical methods, and study materials will be made available to other researchers 
for the purposes of reproducing the results or replicating the procedure upon reasonable 
request. Inquiries can be directed to the corresponding author.
Mouse models
All mouse experiments were conducted in accordance with an approved IACUC protocol at 
the Icahn School of Medicine at Mount Sinai and were in compliance with institutional and 
governmental regulations (PHS Animal Welfare Assurance A3111–01). Nkx2.5H2B-GFP/+, 
cTNTH2B-GFP/+, c-KitH2B-GFP/+, and ROSA26RtdTomato/+ mouse lines were described 
previously12, 39–41. PDGFRαH2B-GFP/+ mice were obtained from Dr. Philippe Soriano42.
Three cassettes (LoxP-4XployA-LoxP-H2B-tdTomato-FRT-Neo-FRT, LoxP-
nLacZ-4XPloyA-LoxP-H2B-GFP-FRT-Neo-FRT and MerCreMer-FRT-Neo-FRT) were 
inserted into the start codon of the Sca-1 (Ly6a) locus to generate Sca-1H2B-tdTomato/+, 
Sca-1nLacZ-H2B-GFP/+ and Sca-1MerCreMer/+ knock-in mouse models, respectively. The 
cassettes were flanked by a 5.0 kb 5ʹ homologous arm and a 4.0 kb 3ʹ homologous arm in 
the targeting constructs. The constructs were linearized and electroporated into mouse 
embryonic stem (ES) cells. Positive ES cells were identified by long-range PCR (Roche) 
with two pairs of primers (P1+P2 and P3+P4). The primer sequences are as follows: P1, 5-
ATGAATAGTTGACCCCCACATGCT-3; P2, 5-CAGGGTGGACCTGCTTCAGAACCT-3 
(Sca-1STOP-H2B-tdTomato/+); P2, 5-GGATGTGCTGCAAGGCGATTAAGT-3 
(Sca-1nLacZ-H2B-GFP/+); P2, 5-GTTCAGCATCCAACAAGGCACTGA-3 (Sca-1MerCreMer/+); 
P3, 5-AGAGCTTGGCGGCGAATGGGCTGACCG-3; and P4, 5-
TGACAACCATCAAGGTTATGATCT-3. The PCR fragments were further subcloned and 
verified by DNA sequencing. Targeted ES cells were microinjected into blastocysts to 
generate chimeric mice. The chimeric mice were crossed with C57BL/6 and Black Swiss 
mice to obtain germline transmission mice. The Neo cassette was removed by crossing with 
Flippase deleter mice. Sca-1H2B-tdTomato/+ mice were obtained by crossing 
Sca-1LoxP−4XPloyA-LoxP-H2B-tdTomato/+ with Protamine-Cre mice.
Tamoxifen (Sigma, cat. T5648) was injected intraperitoneally into the mice at a dose of 0.12 
mg/g body weight.
X-gal staining
Mouse tissues were isolated in ice-cold PBS and fixed in 4% paraformaldehyde for 30 min 
at 4°C. After fixation, the tissues were washed three times with PBS and incubated in X-gal 
solution (5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl2, and 1 
mg/ml X-gal) overnight at room temperature (RT). For section staining, after fixation, the 
tissues were treated with 30% sucrose overnight at 4°C and embedded in optimal cutting 
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temperature (OCT) compound (Tissue-Tek, 4583) on dry ice. Then, 10-μm sections were cut 
and post-fixed in 4% paraformaldehyde for 5 min. The sections were stained with X-gal 
solution overnight at 37°C.
Immunofluorescence
Mouse tissues were perfused with 4% paraformaldehyde, dehydrated with sucrose and 
embedded in OCT. Embedded tissues were cut into 10-μm sections. Sections were blocked 
with 10% donkey serum (Sigma, D9663) in PBS for 1 h at RT and incubated with primary 
antibodies overnight at 4°C. The primary antibodies were goat anti-PECAM (CD31) (1:50, 
R&D Systems, AF3628) and rat anti-Sca-1 (1:200, BD Biosciences, 553333). Sections were 
then incubated with secondary antibodies for 1 h at RT. The secondary antibodies used were 
donkey anti-goat Alexa Fluor 488 (1:500; Invitrogen) and donkey anti-rat Alexa Fluor 594 
(1:500; Invitrogen). Stained sections were mounted with Vectashield mounting medium with 
DAPI (Vector Laboratories). Immunofluorescence images were obtained using a Leica 
fluorescence microscope.
A TSA plus Fluorescein System (Perkin Elmer, NEL741001KT) was used to amplify Sca-1 
antibody fluorescent signals when necessary. After primary antibody incubation, an HRP-
conjugated secondary antibody was applied for 1 h at RT. HRP-conjugated donkey anti-rat 
IgG (1:1000; Invitrogen, A18745) was used as the secondary antibody. Sections were 
washed three times in TNT buffer and amplified with TSA Plus Working Solution for 10 
min at RT.
Myocardial infarction
MI was induced by ligation of the LAD coronary artery as previously described43. Briefly, 
8- to 16-week-old mice were anesthetized with 4% isoflurane before intubation. The left 
thoracic region was trimmed with an electric razor and sterilized with 70% isopropanol. 
After thoracotomy, an 8–0 nylon suture was placed to ligate the LAD. The ribcage and 
muscle layers were closed with 5–0 polypropylene sutures. Excess air and blood was 
removed from the chest cavity, and the skin was closed with 4–0 polypropylene sutures. The 
intubation tube was removed, and mice were housed with moist food and a water bottle.
Heart perfusion and flow cytometry
The procedure for preparing single non-myocardial cells from murine hearts was described 
previously12. Before surgery, mice were injected with heparin. Animals were anesthetized 
by isoflurane inhalation. Hearts were perfused with Ca2+-free collagenase type II solution. 
Atria and connective tissues were removed. Ventricles were cut into small pieces and gently 
dissociated into single cells with a Pasteur pipette. Dissociated single cells were transferred 
into a 50 ml Falcon tube and centrifuged at 10×g for 5 min. Cardiomyocytes formed a cell 
pellet on the bottom. Non-cardiomyocytes were harvested and transferred into a new tube 
without disturbing the cardiomyocyte pellets. The cells were centrifuged at 300×g for 5 min 
and resuspended and incubated in 5–10 ml of 1X RBC (Red Blood Cell) lysis buffer at RT 
for 10 min to remove red blood cells. The cells were collected, washed twice, and 
resuspended in PBS with 0.5% BSA for flow cytometry analysis.
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Bone marrow flow cytometry
Flow cytometric analyses were performed as we previously described44. Mice (8 weeks old) 
were sacrificed for BM cell collection. Single-cell suspensions derived from the BM were 
stained with panels of fluorochrome-conjugated antibodies (Sca-1, BD Biosciences 553108; 
c-Kit, BD Biosciences 560557). Dead cells were excluded by DAPI staining. Analyses were 
performed using an LSRII flow cytometer. All data were analyzed using FlowJo7.6 
software.
Statistical Analysis
Results are shown as mean±SEM. Statistical analysis was performed in Student t test to 
compare data from individual experimental groups. For each group, at least 3–5 animals or 
tissue samples were collected for experimentation.
Results
The new Sca-1H2B-tdTomato reporter mouse recapitulates endogenous Sca-1 expression
To characterize the nature of cardiac Sca-1+ cells, we first generated a Sca-1H2B-tdTomato/+ 
knock-in mouse model by inserting an H2B-tdTomato cassette into the start codon of Sca-1 
(Ly6a) through homologous recombination (Figure S1 A). In this model, Sca-1 genomic 
sequences are preserved. Nuclear tdTomato (H2B-tdTomato) expression is under the control 
of complete Sca-1 regulatory elements, thereby providing a sensitive, robust genetic tool to 
identify endogenous Sca-1+ cells in developing and adult mouse hearts. All 
Sca-1H2B-tdTomato/+ mice were viable and exhibited completely normal development into 
adulthood (>12 months).
To confirm the fidelity of the knock-in allele, we compared tdTomato with endogenous 
Sca-1 expression in various organs of Sca-1H2B-tdTomato/+ mice at postnatal day (P) 60 to 90 
(P60–90). Sca-1H2B-tdTomato expression co-localized with a Sca-1 antibody in multiple cell 
types within the kidney, intestine and lung (Figure S1 C-F). With this reporter line, we also 
detected Sca-1+ cells in the spleen and thymus (data not shown), consistent with previous 
findings that Sca-1 is expressed in these organs45–49. Sca-1 is a cell surface marker that is 
widely used along with c-Kit in the identification of HSCs16, and thus, Sca-1 and tdTomato 
expression should overlap in the c-Kit+ BM cell population from Sca-1H2B-tdTomato/+ mice. 
We tested tdTomato expression on c-Kit+ HSCs of Sca-1H2B-tdTomato/+ mice via flow 
cytometry (Figure S1 G1). Indeed, Sca-1H2B-tdTomato and Sca-1 expression largely 
overlapped (Figure S1 G4). These results further demonstrated that H2B-tdTomato signals in 
Sca-1H2B-tdTomato/+ mice recapitulate endogenous Sca-1 expression.
Heterogeneous Sca-1+ cell populations in postnatal mouse hearts
Next, we used Sca-1H2B-tdTomato/+ mice to identify Sca-1+ cells in the heart. Cardiac Sca-1+ 
cells were found at all postnatal stages inspected (P0, P7, P14, and P30–360), with a low 
number and expression level (based on the brightness of H2B-tdTomato) at birth. The 
number and expression level progressively increased as the heart grew. By P30, 
Sca-1H2B-tdTomato-positive cells were dispersed in all cardiac chambers at high density 
(Figure 1).
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Sca-1+ CSCs were initially described as a population of cells lacking the HSC marker c-
Kit22. However, later studies showed that Sca-1 is widely co-expressed with c-Kit in many 
CSC subtypes (e.g., cardiospheres, side populations, and cardiac colony-forming unit 
fibroblasts)27–32. To obtain a definitive answer regarding cardiac Sca-1 cell identity related 
to c-Kit, we crossed Sca-1H2B-tdTomato/+ mice with c-KitH2B-GFP/+ knock-in mice (Figure 1 
A). Bright, nuclear-localized tdTomato and GFP signals facilitated identification of co-
localization. Hearts from the compound heterozygotes (Sca-1H2B-tdTomato/+;c-KitH2B-GFP/+) 
were collected at P30–120. By directly inspecting sections under a microscope, we found 
that a substantial number of Sca-1H2B-tdTomato-positive cells were also c-KitH2B-GFP-positive 
(Figure 1 B, C). By flow cytometry, we estimated that ~51.8% of Sca-1 H2B-tdTomato-positive 
cells express c-Kit in a 4-month-old heart (Figure 1 D).
Recently, pro-epicardial origin cardiac resident CFU-Fs (colony-forming units–fibroblasts) 
were identified in the adult mouse heart. These cardiac CFU-Fs express platelet-derived 
growth factor receptor α (PDGFRα) and Sca-1 and exhibit mesenchymal stem cell 
properties with multipotency (including cardiomyogenic potential) when cultured in vitro32. 
A new study also showed that PDGFRα+/Sca-1+ side population cells from the adult mouse 
heart are clonogenic and have the capacity to produce cardiomyocytes, endothelial cells, and 
smooth muscle cells after cardiac grafting50. To further characterize cardiac Sca-1+ cells and 
their relationship with PDGFRα, we crossed PDGFRα H2B-GFP/+ knock-in mice with 
Sca-1H2B-tdTomato/+ mice (Figure 1 E). Cryosections of 
Sca-1H2B-tdTomato/+;PDGFRαH2B-GFP/+ mouse hearts were examined at P60–240. 
Sca-1H2B-tdTomato/PDGFRaH2B-GFP double-positive cells were widely observed in all 
cardiac chambers (Figure 1 F, G). Flow cytometry revealed that ~49.3% of Sca-1 
H2B-tdTomato
 cells express PDGFRα in a 3-month-old heart (Figure 1 H).
Exogenously expanded cardiac Sca-1+ cells were shown to express early cardiomyogenic 
markers, including Nkx2.5, Gata4 and Mef2c, upon treatment with oxytocin23. Lineage 
tracing with a Sca-1 transgenic mouse model also showed that Sca-1+ cells continuously 
contribute to myocardial turnover during physiological aging at adulthood51. If any subset of 
cardiac resident Sca-1+ cells acts as intrinsic stem cells that provide a progenitor pool for 
myocardial growth during heart maturation after birth or myocardial turnover during aging 
at adulthood, we speculate that these Sca-1+ cells may transiently express the 
cardiomyogenic marker Nkx2.5 during progenitor to cardiomyocyte conversion. Therefore, 
we attempted to determine whether any cardiac Sca-1+ cells simultaneously express Nkx2.5 
in postnatal hearts. Nkx2.5H2B-GFP/+ knock-in mice were crossed with Sca-1H2B-tdTomato/+ 
mice (Figure 1 I), and cardiac tissues of the compound heterozygous animals 
(Nkx2.5H2B-GFP/+;Sca-1H2B-tdTomato/+) were rigorously examined at P30–180 (15–30 day 
intervals between stages). Surprisingly, we did not find any Sca-1H2B-tdTomato and 
Nkx2.5H2B-GFP double-positive cells at any of the stages examined (Figure 1 J, K).
Cardiac troponin T (cTnT) is an indicator of differentiated cardiomyocytes. Stable 
fluorescence of the H2B-tdTomato fusion protein from Sca-1H2B-tdTomato/+ mice may allow 
short-term cell lineage tracing52, 53 and detection of Sca-1 and cTnT double-positive cells 
when Sca-1+ progenitor cells differentiate into cardiomyocytes. To determine whether Sca-1 
is expressed in cardiomyocytes, cTnTH2B-GFP/+ mice were crossed with Sca-1H2B-tdTomato/+ 
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mice (Figure 1 L). Cardiac sections of the compound heterozygous mice 
(Sca-1H2B-tdTomato/+;cTnTH2B-GFP/+) at P30–180 (15–30-day interval between stages) were 
thoroughly examined. However, no Sca-1H2B-tdTomato and cTnTH2B-GFP double-positive 
cells were found at any of the stages examined (Figure 1 M, N).
Cardiac resident Sca-1+ cells are of the Tie2 endothelial lineage
To further determine the identity of Sca-1+ cells throughout heart formation, we generated a 
dual-reporter mouse line Sca-1nLacZ-H2B-GFP/+ in which a LoxP-nLacZ-4XPolyA-LoxP-
H2B-GFP cassette was inserted into the start codon of Sca-1 (Ly6a) through homologous 
recombination (Figure S2 A, B). The nLacZ cassette was flanked by two LoxP sites, and 
thus, Sca-1H2B-GFP expression is initiated when the nlacZ cassette is removed by Cre 
excision. We performed whole-mount X-gal staining on various tissues/organs from 
Sca-1nLacZ-H2B-GFP/+ mice. nLacZ signals were detected in the kidney, lung, spleen, thymus, 
intestine, and stomach, consistent with previous reports45–49 and observations of 
Sca-1H2B-tdTomato/+ mice (Figure S2 C-J).
We crossed Sca-1nLacZ-H2B-GFP/+ mice with endothelial-specific Tie2Cre mice54 to determine 
endothelial identity and to ascertain how many Sca-1+ cells are of the cardiac 
endothelium30, 35, 37, 55. X-gal staining was performed on the hearts of 
Sca-1nLacZ-H2B-GFP/+;Tie2Cre mice as well as Sca-1nLacZ-H2B-GFP/+ control littermates at 
P30–120 (15–30-day interval between stages) (Figure 2 B-M). In Sca-1nLacZ-H2B-GFP/+ 
hearts, we detected a vast number of Sca-1nLacZ-positive cells. However, hardly any (nearly 
zero) X-gal+ cells were found in Sca-1nLacZ-H2B-GFP/+;Tie2Cre hearts at any of the stages 
detected. We performed immunostaining on Sca-1nLacZ-H2B-GFP/+;Tie2Cre cardiac tissues 
with an anti-PECAM (CD31) antibody. Sca-1H2B-GFP-positive cells generated by Tie2Cre 
excision were co-localized with PECAM (Figure 2 N-Q). These results conclusively suggest 
that cardiac Sca-1+ cells are purely of the Tie2 endothelial lineage.
Sca-1 does not label any cardiac precursor cells during early embryonic heart formation
Currently, the developmental origin of cardiac Sca-1+ cells remains unknown. If resident 
Sca-1+ cells represent a population of CSCs for myocardial renewal and repair in 
adulthood51, we speculate that Sca-1 could possibly be expressed in early cardiac precursors 
at mid-late gestation, during which cardiac progenitors from the first and second heart field, 
pro-epicardium/epicardium, and cardiac neural crest progressively migrate and differentiate 
to form a four-chambered heart with great arteries56–58. Therefore, we performed X-gal 
staining to search for Sca-1+ cells in E7.0-P0 hearts of Sca-1nLacZ-H2B-GFP/+ mice. In fact, 
Sca-1 expression was not detected in any of the early cardiogenic regions (including cardiac 
crescent at E7.0–7.5, first and second heart field at E8.0–9.5, pro-epicardium/epicardium at 
E8.0–16.5, and cardiac neural crest cells at E8.5–11.5) (Figure S3 A-H). The earliest stage 
with Sca-1nLacZ-positive cells was E17.5 (Figure S3 I-J), consistent with observations of 
Sca-1H2B-tdTomato/+ mice, in which we detected a few Sca-1H2B-tdTomato-positive cells at 
E17.5 but no Sca-1-expressing cells at or before E16.5 (Figure S3 M-P).
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Sca-1+ cells minimally differentiate into cardiomyocytes during homeostasis and aging
To further investigate the differentiation potential of cardiac resident Sca-1+ cells, we 
generated a third knock-in mouse model, Sca-1MerCreMer/+, by inserting an inducible 
MerCreMer cassette into the Ly6a start codon (Figure S4). Sca-1MerCreMer/+ mice were 
crossed with the ROSA26RtdTomato reporter41 to obtain 
Sca-1MerCreMer/+;ROSA26RtdTomato/+ double heterozygous mice (Figure 3 A). To examine 
the potential occurrence of Sca-1MerCreMer leakiness, we examined 10-month-old 
Sca-1MerCreMer/+;ROSA26RtdTomato/+ mouse hearts without tamoxifen induction, and 
tdTomato signals were not detected. Next, we treated Sca-1MerCreMer/+;ROSA26RtdTomato/+ 
mice with tamoxifen at P30, P60 and P120 for 1 month (on days 1, 3, 5, 7, 11, 15, 19, 23 and 
27) (Figure 3 A), and ROSA26RtdTomato cells were detected throughout the hearts (Figure 3 
B). Immunostaining with an anti-PECAM antibody showed that tdTomato cells are PECAM
+
 (Figure 3 C-E), further confirming the endothelial identity of cardiac Sca-1+ cells.
Recent lineage tracing of cardiac Sca-1 cells in a transgenic mouse model carrying a 14-kb 
Sca-1 regulatory element showed that cardiac Sca-1-derived cardiomyocytes continuously 
contribute to myocardial replacement during aging, although the frequency is relatively low 
(an average of 2–5% of total cardiomyocytes at 2–18 months)51. Whether the transgenic 
mouse model utilized in the study represents the endogenous activity of Sca-1+ cells is 
unknown. Therefore, we introduced a super-sensitive cardiomyocyte-specific reporter mouse 
model, cTnTnlacZ-H2B-GFP/+ and crossed it with Sca-1MerCreMer/+ mice. The LoxP-
nLacZ-4XPloyA-LoxP-H2B-GFP cassette was inserted into the cTnT start codon in 
cTnTnlacZ-H2B-GFP/+ mice40. Bright nuclear GFP (cTnTH2B-GFP) was expressed when Cre 
activity was present in the myocardium or myocardial precursor cells (Figure 3 F). In the 
absence of tamoxifen, no GFP+ cells were observed in 
Sca-1MerCreMer/+;cTnTnlacZ-H2B-GFP/+ hearts (data not shown). We injected tamoxifen into 
Sca-1MerCreMer/+;cTnTnlacZ-H2B-GFP/+ mice at P30, P60, P90 and P120. After 1–2 months of 
induction, cardiac tissues were collected at P60, P90, P120 and P180 (Figure 3 F). Very few 
cTnTH2B-GFP-positive cells were found in the cardiac sections examined: only 12, 6, 4 and 0 
cells were detected in whole hearts at P60, P90, P120 and P180, respectively (Figure 3 G). 
To increase Sca-1MerCreMer effectiveness, we administered tamoxifen for 3 months. 
However, the number of cTnTH2B-GFP-positive cells did not significantly change (altogether 
<15 cells in the whole heart, ~0.0012% of total cardiomyocytes). These results suggest that 
the myogenic potential of cardiac resident Sca-1+ cells is exceedingly low or non-existent.
Sca-1+ cells retain their endothelial identity and do not differentiate into cardiomyocytes 
after injury
A previous report showed that transplanted cardiac Sca-1+ cells with telomerase activity 
have the ability to migrate to injured areas of the myocardium22. Lineage tracing in the 
Sca-1 transgenic mouse model also revealed that cardiac Sca-1+ cells exhibited increased 
cardiomyocyte differentiation potential under pathological conditions51. These observations 
may need further evaluation because the transplanted Sca-1+ cells and the transgenic allele-
labeled Sca-1+ cells may not mimic the characteristics of endogenous cardiac Sca-1+ cells.
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To investigate the differentiation potential of resident Sca-1+ cells upon injury, we ligated 
the left anterior descending (LAD) coronary artery of Sca-1H2B-tdTomato/+;Nkx2.5H2B-GFP/+ 
mice and Sca-1H2B-tdTomato/+;cTnTH2B-GFP/+ mice at P60–150 (Figure 4 A-G). These 
sensitive genetic tools allowed us to precisely locate Sca-1-derived cardiomyogenic 
progenitors (Sca-1+/Nkx2.5+) and cardiomyocytes (Sca-1+/cTnT+) when they were present 
in the injured zone. Longitudinal sections of the injured heart showed decreased ventricular 
wall and septum thickness, suggesting acute MI (Figure 4 A). All cardiac sections of 
Sca-1H2B-tdTomato/+;Nkx2.5H2B-GFP/+ mice at 2, 5, 8 and 15 days post-surgery (dps) were 
examined, and Sca-1H2B-tdTomato-positive cells were found in the infarcted zone. However, 
no Sca-1H2B-tdTomato/Nkx2.5H2B-GFP double-positive cells were found (Figure 4 B-D). 
Moreover, we did not find any Sca-1H2B-tdTomato/cTnTH2B-GFP double-positive cells at 5, 8 
and 15 dps in the injured area of Sca-1H2B-tdTomato/+;cTnTH2B-GFP/+ hearts (Figure 4 E-G).
Furthermore, we performed LAD ligation in 
Sca-1MerCreMer/+;cTnTnlacZ-H2B-GFP/+;ROSA26RtdTomato/+ triple heterozygous mice (3–5 
months old). Tamoxifen was administered from 1 dps to 30–120 dps for continuous labeling 
of the Sca-1+ cells (Figure 4 H), and ROSA26RtdTomato signals were detected throughout the 
injured heart, including the infarcted regions, in these animals (indicating efficient 
induction), and exhibited enhanced density in the border zone (Figure 4 J1–2). Examination 
of Sca-1MerCreMer/+;cTnTnlacZ-H2B-GFP/+;ROSA26RtdTomato/+ hearts revealed a very limited 
number of cTnTH2B-GFP-positive cells (Figure 4 K-M). Only ~10 cells (~0.001% of total 
cardiomyocytes) were found in the entire heart at 30, 60, and 120 dps, and none were 
located in the injured area (Figure 4 K-M). These observations confirm the extremely low 
myogenic potential of cardiac resident Sca-1+ cells and suggest that the myogenic potential 
of these cells (if any) is not spontaneously stimulated under pathological conditions. In 
addition, we also performed LAD ligation in Sca-1nLacZ-H2B-GFP/+;Tie2Cre mice (3–6 
months old) and found that Sca-1H2B-GFP-positive cells were distributed in the border zone 
and infarcted area at 3–30 dps, indicating the Sca-1+ cells maintain their endothelial identity 
upon injury (Figure 4 N-Q).
Discussion
In this study, we employed a series of new mouse models to define the nature of cardiac 
resident Sca-1+ cells. These high-fidelity genetic tools avoid potential artifacts from 
immunostaining, and provide definitive conclusions regarding the identity and potency of 
cardiac resident Sca-1+ cells. With these models, we determined that Sca-1 is not expressed 
in early cardiac precursors during embryonic heart formation. Although cardiac Sca-1+ cells 
are heterogeneous, they belong to the Tie2 endothelial lineage exclusively, with minimal 
cardiomyogenic potential under both physiological and pathological conditions. These 
observations challenge the long-standing dogma that resident Sca-1+ cells are intrinsic CSCs 
for myocardial development, renewal and repair.
Previous lineage tracing with a transgenic mouse model carrying a 14-kb Sca-1 genomic 
sequence detected many more Sca-1-derived myocardial cells in the adult mouse heart (~2–
5% of total cardiomyocytes) than we observed in this study using a Sca-1MereCreMer mouse 
model carrying a complete Sca-1 genomic sequence (~0.001% of total cardiomyocytes). We 
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presume that a partial Sca-1 genomic fragment does not recapitulate endogenous Sca-1 
expression. Use of partial promoter fragments has also confounded previous attempts to 
lineage label c-Kit+ cells59. The extremely low number of Sca-1-derived cardiomyocytes 
may not even be functionally essential to the heart. These cells may arise from rare, 
sporadic, and transient Sca-1 expression barely detected in the Sca-1 reporter mice 
(Sca-1H2B-tdTomato).
Previous studies have also suggested that two types of Sca-1+ cells exist in the mouse heart: 
Sca-1+/CD31− and Sca-1+/CD31+30, 35, 37, 55. With Sca-1nLacZ-H2B-GFP/+;Tie2Cre mice, we 
found that all the cardiac resident Sca-1+ cells are of the Tie2 lineage. Endothelial cells are 
known to be heterogeneous with mixed expression of distinct endothelial markers60–62. 
Whether Tie2 labels a slightly larger cardiac endothelial population than CD31 in the adult 
mouse heart remains unknown. This requires further investigation in the future.
Over the past 15 years, reports from various groups have repeatedly demonstrated the 
myogenic potency of cardiac Sca-1+ cells in vitro. Although our study conclusively suggests 
that endogenous cardiac Sca-1+ cells do not primarily convert to cardiomyocytes, our results 
are not in opposition to the multipotency of these cells when they are cultured in vitro. We 
speculate that exogenous expansion of cardiac Sca-1+ cells with specific media and factors 
may “reprogram” them and significantly change their nature. The induced multipotency of 
exogenously expanded Sca-1+ cells does not confirm their cardiomyogenic potential in vivo. 
Indeed, a study that used transplantation of Sca-1+ cells to the injured heart showed very low 
efficiency of myocardial conversion35. Recent study by Ye et al. in which various types of 
cells (including BM cells, cardiospheres, cardiosphere-derived Sca-1+/CD45− cells, and 
human embryonic stem cell-derived cardiomyocytes) were delivered to ischemic hearts 
revealed that all these cells, regardless of their type or origin, almost equivalently reduced 
infarct size and improved cardiac function63. Based on these observations and the 
endothelial nature of cardiac Sca-1+ cells, we believe the major beneficial effects of 
transplanted Sca-1+ cells to injured hearts are not due to cardiomyogenic potential. In the 
future, it will be interesting to investigate whether and how the paracrine effects and/or 
neovascularization of Sca-1+ cells contribute to heart repair given their endothelial identity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Clinical Perspective:
What is new?
• We show that Sca-1 does not label cardiac stem cells in the embryonic or 
adult mouse hearts.
• Cardiac Sca-1+ cells are purely of the Tie2 endothelial lineage.
• Resident Sca-1+ cells rarely contribute to cardiomyocytes during normal 
aging and after injury.
What are the clinical implications?
• The identity of cardiac Sca-1+ cells is endothelium.
• Mechanisms of transplanted Sca-1+ cells in heart repair need to be 
reevaluated
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Figure 1. Heterogeneity of cardiac resident Sca-1+ cells.
(A) Diagram of the Sca-1H2B-tdTomato/+;c-KitH2B-GFP/+ double heterozygous alleles. (B-C) 
Longitudinal sections of Sca-1H2B-tdTomato/+;c-KitH2B-GFP/+ mouse hearts at P30 (B) and 
P120 (C). Partial Sca-1H2B-tdTomato cells and c-KitH2B-GFP cells showed co-localization 
(yellow, arrows in B2 and C2). (D) Flow cytometry analysis of 4-month-old 
Sca-1H2B-tdTomato/+;c-KitH2B-GFP/+ mouse heart cells. (E) Diagram of the 
Sca-1H2B-tdTomato/+;PDGFRaH2B-GFP/+ double heterozygous alleles. (F-G) Longitudinal 
sections of Sca-1H2B-tdTomato/+;PDGFRaH2B-GFP/+ mouse hearts at P60 (F) and P240 (G). 
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Some Sca-1H2B-tdTomato cells and PDGFRaH2B-GFP cells showed co-localization (yellow, 
arrows in F2 and G2). (H) Flow cytometry analysis of 4-month-old 
Sca-1H2B-tdTomato/+;PDGFRaH2B-GFP/+ mouse heart cells. (I) Diagram of the 
Sca-1H2B-tdTomato/+;Nkx2.5H2B-GFP/+ double heterozygous alleles. (J, K) Longitudinal 
sections of Sca-1H2B-tdTomato/+;Nkx2.5H2B-GFP/+ mouse hearts at P30 (M) and P120 (N). 
Sca-1H2B-tdTomato cells (red, arrows in J2 and K2) and NKx2.5H2B-GFP-positive cells (green, 
arrowheads in M2 and N2) were not co-localized. (L) Diagram of the 
Sca-1H2B-tdTomato/+;cTnTH2B-GFP/+ double heterozygous alleles. (M, N) Longitudinal 
sections of Sca-1H2B-tdTomato/+;cTnTH2B-GFP/+ mouse hearts at P30 (J) and P120 (K). No 
Sca-1H2B-tdTomato cells (red, arrows in M2 and N2) were cTnTH2B-GFP-positive (green, 
arrowheads in J2 and K2). LV, left ventricle; RV, right ventricle. n=3 for each stage. Scale 
bar, 100 μm.
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Figure 2. Cardiac resident Sca-1+ cells are of the Tie2 lineage.
(A) Diagram of the Sca-1nLacZ-H2B-GFP/+ reporter allele. Sca-1H2B-GFP is expressed when 
the nlacZ cassette is removed by Cre excision. (B-M) X-gal staining of hearts from 
Sca-1nLacZ-H2B-GFP/+ and Sca-1nLacZ-H2B-GFP/+;Tie2Cre/+ littermate mice at P30 (B, E), P60 
(C, F) and P120 (H-L). D, G, J and M are high-magnification photomicrographs 
corresponding with the areas outlined in C, F, I and L (white rectangle). Numerous 
Sca-1nLacZ-positive cells were observed in Sca-1nLacZ-H2B-GFP/+ hearts (arrows in B, C D, 
H, I and J), but no X-gal-positive cells were seen in Sca-1nLacZ-H2B-GFP/+;Tie2Cre/+ hearts. 
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(N-Q) Z-stack images of immunostaining with an anti-PECAM antibody (red) of 
Sca-1nLacZ-H2B-GFP/+;Tie2Cre/+ hearts at P60 (N, O) and P120 (P, Q). Sca-1H2B-GFP-positive 
cells co-localized with PECAM (yellow, arrows in O and Q). LA, left atria; LV, left 
ventricle; RA, right atria; RV, right ventricle. n=3 for each stage. Black scale bar, 1 mm. 
White scale bar, 100 μm.
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Figure 3. Sca-1+ cells in the adult heart have minimal myogenic potential.
(A) Diagram of the Sca-1MerCreMer/+ allele. Sca-1MerCreMer/+ mice were crossed with the 
ROSA26RtdTomato reporter to obtain Sca-1MerCreMer/+;ROSA26RtdTomato/+ double 
heterozygous mice. Tamoxifen was administered 9 times in one month (days 1, 3, 5, 7, 11, 
15, 19, 23 and 27) to induce Sca-1MerCreMer expression. (B) A representative 
Sca-1MerCreMer/+;ROSA26RtdTomato/+ heart showed substantial ROSA26RtdTomato-positive 
cells present after tamoxifen treatment (red, arrows in B2). (C-E) Immunostaining with an 
anti-PECAM antibody (green) of Sca-1MerCreMer/+;ROSA26RtdTomato/+ hearts at P30, P60 
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and P90 after 1 month of tamoxifen treatment. ROSA26RtdTomato cells co-localized with 
PECAM staining in these hearts (yellow, arrows in C2, D2 and E2). (F) Diagram of the 
Sca-1MerCreMer/+;cTnTnLacZ-H2B-GFP/+ double heterozygous alleles. cTnT2H2B-GFP was 
expressed when Cre activity was specifically induced in cardiomyocytes. Hearts were 
collected after 1 month of tamoxifen treatment. (G) All cryosections (10 μm) of 
Sca-1MerCreMer/+;cTnTnLacZ-H2B-GFP/+ mouse hearts at P60, P90, P120 and P180 were 
examined under a microscope. Very few GFP cells were detected (arrows in G), and the total 
number was determined and is shown in the corner. LV, left ventricle; RV, right ventricle. 
Black scale bar, 1 mm. White scale bar, 100 μm.
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Figure 4. Resident Sca-1+ cells do not convert into cardiomyocytes upon injury.
(A) Longitudinal sections of Sca-1H2B-tdTomato/+ mouse hearts showing that Sca-1+ cells 
(arrow) are present in the injured area at 5 days post-surgery (dps). Sections were 
counterstained with DAPI. The infarcted region is indicated by asterisks. (B-D) 
Sca-1H2B-tdTomato/+;Nkx2.5H2B-GFP/+ mouse hearts were collected at 2 dps (B), 5 dps (C) 
and 8 dps (D). No Sca-1H2B-tdTomato (arrows in B, C and D) and Nkx2.5H2B-GFP 
(arrowheads in B, C and D) double-positive cells were found in the infarcted area. (E-G) 
Sca-1H2B-tdTomato/+;cTnTH2B-GFP/+ mouse hearts were collected at 5 dps (E), 8 dps (F) and 
Zhang et al. Page 22
Circulation. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
15 dps (G). Sca-1H2B-tdTomato cells in the injured area (arrows in E, F and G) were not co-
localized with cTnTH2B-GFP cells (arrowheads in E, F and G). (H) Diagram of time points 
for LAD surgery and tamoxifen administration for 
Sca-1MereCreMer/+;cTnTnlacZ-H2B-GFP/+;ROSA26RtdTomato/+ triple heterozygous mice. (I-J) 
Representative whole-mount view of 
Sca-1MereCreMer/+;cTnTnlacZ-H2B-GFP/+;ROSA26RtdTomato/+ mouse heart at 60 dps (I). 
ROSA26RtdTomato-positive cells were detected throughout the heart, including the infarcted 
region (arrows in J3). J2 and J3 are high-magnification images of the border zone (J2) and 
infarcted area (J3) in J1. Asterisks in J1–3 indicate the infarcted region. (K-M) Longitudinal 
sections of Sca-1MereCreMer/+;cTnTnlacZ-H2B-GFP/+;ROSA26RtdTomato/+ hearts at 30 dps (K), 
60 dps (L) and 120 dps (M). ROSA26RtdTomato cells were detected in the infarcted region 
(arrows in K-M). No cTnTH2B-GFP-positive cells were detected in the infarcted region at 30, 
60 and 120 dps. M2 is the green fluorescence filter image of M1 and shows the absence of 
cTnTH2B-GFP-positive cells. (N-O) Sca-1H2B-GFP-positive endothelial cells in the infarcted 
region of Sca-1nLacZ-H2B-GFP/+;Tie2Cre hearts at 30 dps. N2 and O2 are high-magnification 
photomicrographs corresponding to the areas outlined in N1 and O1. Black scale bar, 1 mm. 
White scale bar, 100 μm.
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